Literature DB >> 23645646

Sepsis caused by Mycobacterium terrae complex in a patient with sickle cell disease.

Ashwini K Esnakula1, Sudhir K Mummidi, Patricia A Oneal, Tammey J Naab.   

Abstract

Infections are a significant cause of morbidity and mortality in patients with sickle cell disease. Loss of splenic function in these patients makes them highly susceptible to some bacterial infections. Non-tuberculous mycobacterial infections in patients with sickle cell disease are extremely rare and only two cases have been reported previously. We describe a case of sepsis caused by non-tuberculous mycobacterium, Mycobacterium terrae complex in a patient with febrile sickle cell disease. M terrae complex is a rare clinical pathogen and this is the first reported case of sepsis secondary to this organism in a patient with sickle cell disease. The patient responded to imipenem and amikacin therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23645646      PMCID: PMC3669932          DOI: 10.1136/bcr-2013-009159

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Salmonella osteomyelitis in sickle cell disease children in the east end of London.

Authors:  B L Atkins; E H Price; L Tillyer; V Novelli; J Evans
Journal:  J Infect       Date:  1997-03       Impact factor: 6.072

2.  A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection.

Authors:  Pramila Venigalla; Bharat Motwani; Sandra Allen; Manoj Agarwal; Manuel Alva; Maxwell Westerman; Lawrence Feldman
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

Review 3.  Epidemiology of disease caused by nontuberculous mycobacteria.

Authors:  C R Horsburgh
Journal:  Semin Respir Infect       Date:  1996-12

4.  Plesiomonas shigelloides sepsis in a thalassemia intermedia patient.

Authors:  Revekka Tzanetea; Kostas Konstantopoulos; Anna Xanthaki; Vassiliki Kalotychou; Chara Spiliopoulou; Argyris Michalopoulos; Yannis Rombos
Journal:  Scand J Infect Dis       Date:  2002

5.  IFN-gamma low production capacity in type 1 diabetes mellitus patients at onset of disease.

Authors:  M A Avanzini; L Ciardelli; E Lenta; A M Castellazzi; M Marconi; G Derosa; C Dos Santos; M Oliveri; A Pistorio; R Lorini; G d'Annunzio
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-06       Impact factor: 2.949

Review 6.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  Infectious complications in sickle cell disease are influenced by HLA class II alleles.

Authors:  Ryad Tamouza; Maria Grazia Neonato; Marc Busson; François Marzais; Robert Girot; Dominique Labie; Jacques Elion; Dominique Charron
Journal:  Hum Immunol       Date:  2002-03       Impact factor: 2.850

8.  Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia.

Authors:  Malika Benkerrou; Charlotte Delarche; Lamia Brahimi; Michèle Fay; Etienne Vilmer; Jacques Elion; Marie-Anne Gougerot-Pocidalo; Carole Elbim
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

9.  Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.

Authors:  V F Larcher; R J Wyke; L R Davis; C E Stroud; R Williams
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

10.  Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.

Authors:  Martin Spatz; Nicole Eibl; Sandra Hink; Hermann M Wolf; Gottfried F Fischer; Wolfgang R Mayr; Guntram Schernthaner; Martha M Eibl
Journal:  Cell Immunol       Date:  2003-01       Impact factor: 4.868

View more
  1 in total

1.  Clinical and Laboratory Characteristics of Patients with Nontuberculous Mycobacterium Bloodstream Infection in a Tertiary Referral Hospital in Beijing, China.

Authors:  Sai-Nan Bian; Li-Fan Zhang; Yue-Qiu Zhang; Qi-Wen Yang; Peng Wang; Ying-Chun Xu; Xiao-Chun Shi; Xiao-Qing Liu
Journal:  Chin Med J (Engl)       Date:  2016-09-20       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.